相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Weight Change From 3-Year Observational Data
Chris J. Bushe et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Weight changes over time in adults treated with the oral or depot formulations of olanzapine: a pooled analysis of 86 clinical trials
Brian A. Millen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Intentional Weight Loss in Overweight and Obese Patients With Severe Mental Illness: 8-Year Experience of a Behavioral Treatment Program
Richard I. G. Holt et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
Diego Novick et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies
C. J. Bushe et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients*
J. Karagianis et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course
Stefan Gebhardt et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications
S. Gentile
OBESITY REVIEWS (2009)
Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: Effect modification or regression to the mean?
David B. Allison et al.
PSYCHIATRY RESEARCH (2009)
Results of phase 3 of the CATIE schizophrenia trial
T. Scott Stroup et al.
SCHIZOPHRENIA RESEARCH (2009)
Weight management in a cohort of Irish inpatients with serious mental illness (SMI) using a modular behavioural programme. A preliminary service evaluation
Chris J. Bushe et al.
BMC PSYCHIATRY (2008)
Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain - A randomized controlled trial
Ren-Rong Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder:: an open randomised clinical trial
Rene S. Kahn et al.
LANCET (2008)
Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia:: A 12-week double-blind, placebo-controlled pilot study
Trino Baptista et al.
PSYCHIATRY RESEARCH (2008)
Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: Findings of a randomized clinical trial in a drug-naive population
Rocio Perez-Iglesias et al.
SCHIZOPHRENIA RESEARCH (2008)
A well-being programme in severe mental illness. Reducing risk for physical ill-health: A post-programme service evaluation at 2 years
Shubulade Smith et al.
EUROPEAN PSYCHIATRY (2007)
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: A 100-week, double-blind study versus placebo
Paul E. Keck et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Changes in body mass index in Canadians over a five-year period: Results of a prospective, population-based study
Wilma M. Hopman et al.
BMC PUBLIC HEALTH (2007)
Weight development in patients treated with risperidone:: a 5-year naturalistic study
M. Neovius et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Long-term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK
J. Pendlebury et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: Observational versus randomized studies results
Josep Maria Haro et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study
M Lambert et al.
ACTA PSYCHIATRICA SCANDINAVICA (2005)
分享论文
